Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cuddle power: can kangaroo care boost breast milk quality?

NCT ID NCT06047470

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how kangaroo care (holding your baby skin-to-skin) changes the nutrients and amount of breast milk in parents whose babies are in the NICU and can't breastfeed directly. About 25 parents will provide milk samples after holding their baby and after no contact, so researchers can compare the calories, fat, protein, and volume. The goal is to understand if this simple bonding practice improves milk for vulnerable infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Lactating Parent/Infant Dyads: 1. Lactating parents of infants who are currently admitted to the UCDMC NICU and are expected to remain in the NICU for at least 2 weeks from study enrollment 2. Lactating parent is 18 years of age or older 3. Infant with prematurity or other conditions prohibiting nutritive feeding at the breast during the study period 4. Lactating parent plans to feed their infants breast milk for at least 1 month 5. Lactating parent is willing to refrain from tandem feeding another child during the study period 6. Willing to refrain from enrolling infant in an interventional research study that may impact growth or feeding tolerance during the study period 7. Lactating parent is willing to use a hospital grade pump available in the NICU to express milk for sample collection 8. Lactating Parent that is willing to travel to UCDMC on 4 occasions within a 10 day period for study visits Providers/staff: 1\. Physicians, nurses, fellows, residents, and NICU staff involved in the implementation of Kangaroo care for the MILK study. Exclusion Criteria: 1. Infant less than 1 week of age at enrollment 2. Lactating parents expressing breast milk for more than one infant 3. Lactating parents who are currently or plan to tandem feed another child during the study period 4. Lactating parents that are participating in an interventional research study that could influence breast milk production. 5. Lactating parents with infants deemed by primary investigator/primary care team to be too unstable for kangaroo care 6. Lactating parents that are unwilling to participate in kangaroo care 7. Dyads that have participated in nutritive feeding at the breast 8. Lactating parents that use recreational drugs that contraindicate breastfeeding/provision of breast milk 9. Lactating parents taking therapies, supplements, or medications that are incompatible with breastfeeding/provision of breast milk to their infant 10. Lactating parents using, or planning to use, any over-the-counter or prescription medication for the purpose of increasing milk supply (including domperidone, fenugreek, turmeric, blessed milk thistle, Brewer's yeast, or lactation cookies) 11. Lactating parents that are involuntarily confined 12. Lactating parents that are adults unable to consent 13. Lactating parents unwilling to travel to UC Davis NICU for study visits 14. Anyone deemed unfit for participation by the investigator(s)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lactation disorder with baby delivered are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Infant Nutrition Disorders lactation disease nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UC Davis

    Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.